Literature DB >> 24311634

BRAF-V600E mutation in pediatric and adult glioblastoma.

Sonika Dahiya1, Ryan J Emnett, Devon H Haydon, Jeffrey R Leonard, Joanna J Phillips, Arie Perry, David H Gutmann.   

Abstract

Entities:  

Keywords:  brain tumor; children; glioma; microarray

Mesh：

Substances：

Year:  2013        PMID： 24311634      PMCID： PMC3895374          DOI： 10.1093/neuonc/not146

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  16 in total

1.  Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Authors:  Genevieve Schindler; David Capper; Jochen Meyer; Wibke Janzarik; Heymut Omran; Christel Herold-Mende; Kirsten Schmieder; Pieter Wesseling; Christian Mawrin; Martin Hasselblatt; David N Louis; Andrey Korshunov; Stefan Pfister; Christian Hartmann; Werner Paulus; Guido Reifenberger; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2011-01-29       Impact factor: 17.088

2.  Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Caterina Giannini; Sandra C Bryant; Robert B Jenkins
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

3.  Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.

Authors:  Yongji Tian; Benjamin E Rich; Natalie Vena; Justin M Craig; Laura E Macconaill; Veena Rajaram; Stewart Goldman; Hala Taha; Madeha Mahmoud; Memet Ozek; Aydin Sav; Janina A Longtine; Neal I Lindeman; Levi A Garraway; Azra H Ligon; Charles D Stiles; Sandro Santagata; Jennifer A Chan; Mark W Kieran; Keith L Ligon
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

4.  Mutation analysis of B-RAF gene in human gliomas.

Authors:  Diana Basto; Vítor Trovisco; José M Lopes; Albino Martins; Fernando Pardal; Paula Soares; Rui M Reis
Journal:  Acta Neuropathol       Date:  2004-11-17       Impact factor: 17.088

5.  BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.

Authors:  C Koelsche; F Sahm; W Paulus; M Mittelbronn; F Giangaspero; M Antonelli; J Meyer; F Lasitschka; A von Deimling; D Reuss
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

6.  Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

Authors:  Margaret J Dougherty; Mariarita Santi; Marcia S Brose; Changqing Ma; Adam C Resnick; Angela J Sievert; Phillip B Storm; Jaclyn A Biegel
Journal:  Neuro Oncol       Date:  2010-02-14       Impact factor: 12.300

7.  Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

Authors:  Joshua D Schiffman; J Graeme Hodgson; Scott R VandenBerg; Patrick Flaherty; Mei-Yin C Polley; Mamie Yu; Paul G Fisher; David H Rowitch; James M Ford; Mitchel S Berger; Hanlee Ji; David H Gutmann; C David James
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

8.  Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.

Authors:  J Yu; H Deshmukh; R J Gutmann; R J Emnett; F J Rodriguez; M A Watson; R Nagarajan; D H Gutmann
Journal:  Neurology       Date:  2009-09-30       Impact factor: 9.910

9.  BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

Authors:  Dora Dias-Santagata; Quynh Lam; Kathy Vernovsky; Natalie Vena; Jochen K Lennerz; Darrell R Borger; Tracy T Batchelor; Keith L Ligon; A John Iafrate; Azra H Ligon; David N Louis; Sandro Santagata
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

10.  Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.

Authors:  K Jacob; S Albrecht; C Sollier; D Faury; E Sader; A Montpetit; D Serre; P Hauser; M Garami; L Bognar; Z Hanzely; J L Montes; J Atkinson; J-P Farmer; E Bouffet; C Hawkins; U Tabori; N Jabado
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640
View more
  32 in total

Review 1.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults.

Authors:  Norman L Lehman; Eyas M Hattab; Bret C Mobley; Aisulu Usubalieva; Matthew J Schniederjan; Roger E McLendon; Werner Paulus; Elisabeth J Rushing; Maria-Magdalena Georgescu; Marta Couce; Mohanpal S Dulai; Mark L Cohen; Christopher R Pierson; Jack M Raisanen; Sarah E Martin; Trang D Lehman; Eric S Lipp; Jose M Bonnin; Mousa A Al-Abbadi; Kara Kenworthy; Kevin Zhao; Nehad Mohamed; Guojuan Zhang; Weiqiang Zhao
Journal:  Neuro Oncol       Date:  2016-07-14       Impact factor: 12.300

Review 3.  New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.

Authors:  Michael Karsy; Jian Guan; Adam L Cohen; Randy L Jensen; Howard Colman
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

4.  Assessment of genetic variant burden in epilepsy-associated brain lesions.

Authors:  Lisa-Marie Niestroj; Patrick May; Mykyta Artomov; Katja Kobow; Roland Coras; Eduardo Pérez-Palma; Janine Altmüller; Holger Thiele; Peter Nürnberg; Costin Leu; Aarno Palotie; Mark J Daly; Karl Martin Klein; Rudi Beschorner; Yvonne G Weber; Ingmar Blümcke; Dennis Lal
Journal:  Eur J Hum Genet       Date:  2019-07-29       Impact factor: 4.246

5.  BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Authors:  Angela C Hirbe; Melike Pekmezci; Sonika Dahiya; Anthony J Apicelli; Brian A Van Tine; Arie Perry; David H Gutmann
Journal:  Neuro Oncol       Date:  2013-12-22       Impact factor: 12.300

Review 6.  RAF and MEK inhibitor therapy in adult patients with brain tumors: a case-based overview and practical management of adverse events.

Authors:  Karisa C Schreck; Mallika P Patel; Jan Wemmer; Stuart A Grossman; Katherine B Peters
Journal:  Neurooncol Pract       Date:  2020-02-27

Review 7.  RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction.

Authors:  Jian Zhong
Journal:  Biol Chem       Date:  2016-03       Impact factor: 3.915

8.  Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.

Authors:  Mary Jane Lim-Fat; Kun Wei Song; J Bryan Iorgulescu; Brian M Andersen; Deborah A Forst; Justin T Jordan; Elizabeth R Gerstner; David A Reardon; Patrick Y Wen; Isabel Arrillaga-Romany
Journal:  J Neurooncol       Date:  2021-03-01       Impact factor: 4.130

9.  BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage.

Authors:  Wei Wang; Maode Wang; Haitao Jiang; Tuo Wang; Rong Da
Journal:  BMC Neurol       Date:  2021-05-12       Impact factor: 2.474

10.  Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members.

Authors:  Shannon Fortin Ensign; Maya Hrachova; Susan Chang; Maciej M Mrugala
Journal:  Neurooncol Pract       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.